Cargando…
Safety and efficacy of P2Et extract from Caesalpinia spinosa in breast cancer patients: study protocol for a randomized double blind phase II clinical trial (CS003-BC)
BACKGROUND: Chemotherapy in breast cancer is effective but can generate significant toxicity and lead to tumor resistance. Joint treatment with standardized plant extracts can be an alternative to improve the response and allow an effective activation of the antitumor immune response that favors rec...
Autores principales: | Ballesteros-Ramírez, Ricardo, Pinilla, Paola, Sanchéz, Jesús, Torregrosa, Lilian, Aschner, Pablo, Urueña, Claudia, Fiorentino, Susana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478348/ https://www.ncbi.nlm.nih.gov/pubmed/37670337 http://dx.doi.org/10.1186/s12906-023-04139-w |
Ejemplares similares
-
Safety Evaluation in Healthy Colombian Volunteers of P2Et Extract Obtained from Caesalpinia spinosa: Design 3+3 Phase I Clinical Trial
por: Duran, María I, et al.
Publicado: (2022) -
Genotoxicity and mutagenicity assessment of a standardized extract (P2Et) obtained from Caesalpinia spinosa
por: Ballesteros-Ramírez, R., et al.
Publicado: (2020) -
An Immunomodulatory Gallotanin-Rich Fraction From Caesalpinia spinosa Enhances the Therapeutic Effect of Anti-PD-L1 in Melanoma
por: Lasso, Paola, et al.
Publicado: (2020) -
Gallotannin-rich Caesalpinia spinosa fraction decreases the primary tumor and factors associated with poor prognosis in a murine breast cancer model
por: Urueña, Claudia, et al.
Publicado: (2013) -
A gallotannin-rich fraction from Caesalpinia spinosa (Molina) Kuntze displays cytotoxic activity and raises sensitivity to doxorubicin in a leukemia cell line
por: Castañeda, Diana M, et al.
Publicado: (2012)